| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 03/01/2006 | EP1628674A2 Protease inhibitors for coronaviruses and sars-cov and the use thereof |
| 03/01/2006 | EP1325739B1 Liposomes encapsulating anticancer drugs and the use thereof in the treatment of malignant tumors |
| 03/01/2006 | EP1162991B1 Arginine-rich anti-vascular endothelial growth factor peptides that inhibit growth and metastasis of human tumor cells by blocking angiogenesis |
| 03/01/2006 | EP1141250B1 Intein-mediated cyclization of peptides |
| 03/01/2006 | EP1105409B1 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 03/01/2006 | EP0981364B1 Method and compositions for treating hyperlipidemia |
| 03/01/2006 | EP0979241B1 (3r)-3-amino-4-carboxybutyraldehyde derivatives inhibiting the release of interleukin-1/beta |
| 03/01/2006 | EP0840750B1 Ha-2 antigenic peptide |
| 03/01/2006 | CN1741809A Peptides which target tumor and endothelial cells, compositions and uses thereof |
| 03/01/2006 | CN1741808A Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof |
| 03/01/2006 | CN1740143A Prepn process of metal-amino acid chelate |
| 03/01/2006 | CN1739787A Orally administered peptides to ameliorate atherosclerosis |
| 02/28/2006 | US7005420 Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides |
| 02/28/2006 | US7005417 Echinocandin derivatives, method for preparing same and use as antifungal agents |
| 02/25/2006 | CA2479163A1 Novel leptin antagonist |
| 02/24/2006 | CA2516876A1 Antibodies which are directed against the marburg i polymorphism of factor vii-activating protease (fsap), and their preparation and use |
| 02/23/2006 | WO2006020981A2 Methods for accelerating bone growth and repair |
| 02/23/2006 | WO2005123761A8 GnRH ANALOGS BACKBONE CYCLIZED THROUGH METAL COMPLEXATION |
| 02/23/2006 | WO2004043383A3 A new target for angiogenesis and anti-angiogenesis therapy |
| 02/23/2006 | US20060041164 liver X receptor LXR agonists; increasing ABCA1, ABCG1, and apolipoprotein E expression, increasing cholesterol efflux from peripheral cells, cardiovascular disease, inflammation; 2-(3-{3-[[2-Chloro-3-(trifluoromethyl)benzyl](2,2-diphenylethyl)amino]-2-methyl-propoxy}-phenyl)acetic acid methyl ester |
| 02/23/2006 | US20060041105 Peptides whose uptake by cells is controllable |
| 02/23/2006 | US20060040866 Peptides and compounds that bind to a receptor |
| 02/23/2006 | US20060040858 Novel peptides that bind to the erythropoietin receptor |
| 02/23/2006 | US20060040857 1-Desamino-8-a-arginyl vasopressin analogs |
| 02/23/2006 | US20060040324 Methods for making metallopeptides and metallopeptide libraries |
| 02/23/2006 | US20060040307 A recombinant human telomerase reverse transcriptase (hTRT) protein; drug screening for antiproliferative agents that inhibit hTRT activity; cancer diagnosis and prognosis; anticarcinogenic agents |
| 02/23/2006 | US20060039924 Peptide having modified arginine residue; detecting autoimmune antibodies against rheumatoid arthritis |
| 02/23/2006 | US20060039918 Stress proteins and peptides and methods of use thereof |
| 02/23/2006 | US20060039861 For magnetic resonance imaging (MRI); peptide modified at its N- and its C-termini, independently, with a moiety comprising a metal chelate complex; specific binding affinity for fibrin; sufficient half-life in vivo |
| 02/23/2006 | CA2600906A1 New peptidic and peptidoid bradykinin b1 receptor antagonists and uses thereof |
| 02/23/2006 | CA2577597A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor |
| 02/23/2006 | CA2575058A1 Antimicrobial peptides comprising an arginine- and/or lysine-containing motif |
| 02/22/2006 | EP1626984A1 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease |
| 02/22/2006 | EP1121431B1 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 02/22/2006 | CN1739029A Prion protein ligands and methods of use |
| 02/22/2006 | CN1738652A Improved linkers for pharmaceutical compounds |
| 02/22/2006 | CN1737009A Polypeptide compound and its medicinal uses |
| 02/22/2006 | CN1243014C Adherence peptide specific to tissue of liver cancer obtained through sieve method in vitro, and usage |
| 02/22/2006 | CN1243013C Adherence peptide specific to tissue of liver cancer, in vivo and in vitro combined screen method, and usage |
| 02/21/2006 | US7001983 Non-hemolytic cytolytic peptides;antibacterial, anticancer, antiprotozoal agents |
| 02/21/2006 | US7001982 Non-natural C-linked carbo-β-peptides with robust secondary structures |
| 02/21/2006 | CA2091181C Cloning of chicken anaemia dna |
| 02/16/2006 | WO2006017619A2 Receptor-binding cyclic peptides and methods of use |
| 02/16/2006 | WO2006016558A1 Novel strains belonging to the genus paenibacillus and method of controlling plant disease by using these strains or culture thereof |
| 02/16/2006 | WO2005118630A3 Peptides for the treatment of diabetes |
| 02/16/2006 | WO2005116068A8 Peptides or peptidic conjugate derivatives of msh and the use thereof for cosmetically fighting against canities |
| 02/16/2006 | WO2005066633A3 Fluorescent ligands for gpcr arrays |
| 02/16/2006 | WO2004106359A3 Self-assembled peptide-amphiphiles & self-assembled peptide nanofiber networks presenting multiple signals |
| 02/16/2006 | US20060036073 Neurotrophic and neuroprotective peptides |
| 02/16/2006 | US20060036071 Processes for preparing eptifibatide |
| 02/16/2006 | US20060036070 Immunoglobulin a inducing protein and uses therefor |
| 02/16/2006 | US20060035839 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 02/16/2006 | US20060035837 Compounds that inhibit Hsp90 protein-protein interactions with IAP proteins |
| 02/16/2006 | US20060035822 Analogs which are topically active but systemically less active, providing therapy to subjects without the risk of systemic side effects |
| 02/16/2006 | US20060035821 Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases |
| 02/16/2006 | US20060035820 Fungicides trans 1-[4-[(2-aminocyclo-hexyl)-amino]N2-[[4''(pentyloxy)[1,1':4', 1''-terphenyl]-4-yl-carbonyl]-L-ornithine]-4-[4(4-hydroxyphenyl)-L-threonine]-5-L-serine-echinocandine B trifluoroacetate; treating infections caused by Candida, Aspergillus, Cryptococcus |
| 02/16/2006 | US20060035819 Novel molecule |
| 02/16/2006 | US20060035814 Reagents and methods for smooth muscle therapies |
| 02/16/2006 | US20060035325 Regulated apoptosis |
| 02/16/2006 | US20060035305 Synthetic peptides, conjugation reagents and methods |
| 02/16/2006 | US20060035284 Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroup B epitopes |
| 02/16/2006 | US20060035260 Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses |
| 02/16/2006 | US20060035223 Method of isolating binding peptides from a combinatorial phage display library and peptides produced thereby |
| 02/16/2006 | US20060034863 Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof |
| 02/16/2006 | US20060034859 Naturally processed measles virus peptides eluted from class II HLA molecules |
| 02/16/2006 | US20060034855 Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein |
| 02/16/2006 | US20060034839 Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor |
| 02/16/2006 | US20060034759 Production and use of novel peptide-based agents with bispecific antibodies |
| 02/16/2006 | DE19641213B4 Cyclische Peptide, Verfahren zu ihrer Herstellung und ihre Verwendung Cyclic peptides, process for their preparation and their use |
| 02/16/2006 | CA2575769A1 Novel strains belonging to the genus paenibacillus and method of controlling plant disease by using these strains or culture thereof |
| 02/16/2006 | CA2575123A1 Peptide sequence for modulation of delta protein kinase c |
| 02/15/2006 | EP1626055A2 Non-mammalian GnRH analogs and uses thereof in the regulation of the immune system |
| 02/15/2006 | EP1626054A1 Oligopeptide |
| 02/15/2006 | EP1625222A2 Broadening adenovirus tropism |
| 02/15/2006 | EP1625153A1 Acylated lysobactin-type nonadepsipeptides |
| 02/15/2006 | EP1625152A2 Peptides modulating the activity of the engrailed transcription factor |
| 02/15/2006 | EP1625150A1 Tripeptides and derivatives thereof for cosmetic application in order to improve skin structure |
| 02/15/2006 | EP1625148A1 Peptide complex |
| 02/15/2006 | EP1624897A2 Hiv prodrugs cleavable by cd26 |
| 02/15/2006 | EP1624885A2 Synthetic peptide analogs of arg-pro-pro-gly-phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4 |
| 02/15/2006 | EP1624884A2 Somatostatin vectors |
| 02/15/2006 | CN1735426A Peptides as solubilizing excipients for transforming growth factor ss proteins |
| 02/15/2006 | CN1735422A Pept¿¼deos antimicrobianos de novispirin |
| 02/15/2006 | CN1733797A Thymus gland pentapeptide purification technique |
| 02/15/2006 | CN1733796A Thymus gland pentapeptide synthesis technique |
| 02/15/2006 | CN1241936C Polypeptide of inhibiting crown virus and its derivant |
| 02/15/2006 | CN1241935C Liquid phase sgnthesis method of thymus pentapeptide |
| 02/14/2006 | US6998385 Antiinflammatory agents; autoimmune disease |
| 02/14/2006 | US6998383 Inhibitors of receptor activator of NF-κB and uses thereof |
| 02/14/2006 | CA2336597C Hepatitis c inhibitor peptides |
| 02/09/2006 | WO2006014872A2 Novel processes for stereoselective synthesis of trans isatx 247 |
| 02/09/2006 | WO2006014744A2 Compounds that inhibit hsp90 protein-protein interactions with iap proteins |
| 02/09/2006 | WO2006014559A2 Cyclic peptides for treatment of cachexia |
| 02/09/2006 | WO2005111064A8 Cyclopeptide derivatives with anti-integrin activity |
| 02/09/2006 | WO2005095444A3 Synthetic peptides containing the motif ‘ywwlxp’ as anthrax toxin antidotes |
| 02/09/2006 | WO2005042027A3 Antagonists of the bradykinin b1 receptor |
| 02/09/2006 | WO2003040693A3 Peptides that home to tumor lymphatic vasculature and methods of using same |
| 02/09/2006 | US20060030532 Directly contacting bacteria or fungi, especially Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Proteus vulgaris, Enterococcus faecalis, or Candida albicans, with a substance P analog |
| 02/09/2006 | US20060030004 Solid phase synthesis |
| 02/09/2006 | US20060029928 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (prrsv), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a prrsv and a method of detecting a |